A recent scientific study showed that Alteplase is the solvent of the stroke of the stroke patients by more than 50% when giving it within 24 hours after the beginning of the hopper stroke.
The results are given hope for patients with stroke all over the world who may not be able to reach medications to dissolve clots within the time approved in their country.
The study was conducted by researchers at the Second Hospital of the Faculty of Medicine at the University of Zhejiang in China, and the results of the study were presented at the 2025 International Stroke Conference organized by the American Stroke Association, which was held in Los Angeles in the United States from the fifth to the seventh of February present.
stroke
The stroke occurs when blood supply stops for a part of the brain, or decreases significantly, which leads to the interruption of its supply of oxygen and nutrients, and in minutes the brain cells begin to die. Because the brain cells are not renewed, this may lead to permanent damage to the brain.
There are 3 types of strokes:
Stroke
It is caused by the interruption of blood access to the brain as a result of the blockage of one of the arteries leading to it, and this is the result of a blood clot that may form in the brain or come from another place in the body, such as the heart. It increases the possibility of strokes a tight in the arterial arteries. Hosary strokes constitute approximately 85% of the total strokes.
Stroke
It occurs due to bleeding in one of the brain vessels, due to several causes, including high blood pressure and the presence of a weak part in the wall of the blood vessel or a brightness or shock in the head.
Cross is the transitory stroke
It is a type of temporary stroke that occurs as a result of a interruption or a temporary decrease in the brain supply of the blood, and it lasts at least 5 minutes, after which the supply of blood returns to its normal position and therefore no permanent damage to the brain occurs.
Algapels and his family
The body makes an enzyme that helps to dissolve blood clots called “hybumnegine stimulant enzyme”. In the laboratory, humans made an enzyme similar to this enzyme to treat heart attacks, strokes and strokes in the lungs. Altablas is an example of the laboratory enzyme and humans have made other similar enzymes such as “Reteplase” and “TENECTEPLASE”.
Hope for patients
“We believe that these results mean that more people may return to their normal or semi -normal lives after a stroke, even if they received treatment at a later time. It can become the treatment method. This is the new standard, especially in hospitals that use computerized tomography.
This technology helps healthcare professionals to know how blood flows in different parts of the brain after ischy stroke. This can expand the eligibility of treatment for millions of other patients all over the world.
The study concluded that 40% of the participants who were treated with the stings had a few or non -disability after 90 days, compared to 26% of those who received standard care (given according to the current guidelines). The death rates were similar (10.8%) for both groups. As for the danger of cerebral bleeding, it was higher among those who received Al -Alagtels compared to the participants who did not receive it (3.8% compared to 0.5%), but researchers believe that this is a risk that can be managed.
“We also need to look closely at the safety and effectiveness of other stimulus drugs, such as Tenxteplas, when giving them after a stroke, especially after the usual time frames. It is also important to know whether our results apply to other groups of people, Especially in areas where the risk of stroke and health care resources varies.